These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 10980053

  • 41. Recurrent hepatitis C after retransplantation: factors affecting graft and patient outcome.
    Carmiel-Haggai M, Fiel MI, Gaddipati HC, Abittan C, Hossain S, Roayaie S, Schwartz ME, Gondolesi G, Emre S, Schiano TD.
    Liver Transpl; 2005 Dec; 11(12):1567-73. PubMed ID: 16315297
    [Abstract] [Full Text] [Related]

  • 42. Transcriptome at the time of hepatitis C virus recurrence may predict the severity of fibrosis progression after liver transplantation.
    Mas V, Maluf D, Archer KJ, Potter A, Suh J, Gehrau R, Descalzi V, Villamil F.
    Liver Transpl; 2011 Jul; 17(7):824-35. PubMed ID: 21618696
    [Abstract] [Full Text] [Related]

  • 43. Evaluation of liver transplantation for high-risk indications.
    Chung SW, Greig PD, Cattral MS, Taylor BR, Sheiner PA, Wanless I, Cameron R, Phillips MJ, Blendis LM, Langer B, Levy GA.
    Br J Surg; 1997 Feb; 84(2):189-95. PubMed ID: 9052430
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.
    Belli LS, Burroughs AK, Burra P, Alberti AB, Samonakis D, Cammà C, De Carlis L, Minola E, Quaglia A, Zavaglia C, Vangeli M, Patch D, Dhillon A, Cillo U, Guido M, Fagiuoli S, Giacomoni A, Slim OA, Airoldi A, Boninsegna S, Davidson BR, Rolles K, Pinzello G.
    Liver Transpl; 2007 May; 13(5):733-40. PubMed ID: 17370330
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE, Haworth SE, Belli LS, Burra P, Pinzello G, Vangeli M, Minola E, Guido M, Boccagni P, De Feo TM, Torelli R, Cardillo M, Scalamogna M, Poli F.
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [Abstract] [Full Text] [Related]

  • 48. Tissue hepatitis C virus RNA quantification and protein expression help identify early hepatitis C virus recurrence after liver transplantation.
    D'Errico-Grigioni A, Fiorentino M, Vasuri F, Gruppioni E, Fabbrizio B, Zucchini N, Ballardini G, Morelli C, Pinna AD, Grigioni WF.
    Liver Transpl; 2008 Mar; 14(3):313-20. PubMed ID: 18306349
    [Abstract] [Full Text] [Related]

  • 49. Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up.
    Neumann UP, Berg T, Bahra M, Puhl G, Guckelberger O, Langrehr JM, Neuhaus P.
    Transplantation; 2004 Jan 27; 77(2):226-31. PubMed ID: 14742986
    [Abstract] [Full Text] [Related]

  • 50. Liver transplantation and hepatitis C virus. Results in a Spanish center since 1989.
    Loinaz C, Lumbreras C, Moreno E, Colina F, Fuertes A, Gómez R, Jiménez C, González-Pinto I, García I, Rojas J, Bellorín C.
    Hepatogastroenterology; 2001 Jan 27; 48(41):1435-42. PubMed ID: 11677981
    [Abstract] [Full Text] [Related]

  • 51. Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation.
    Sreekumar R, Gonzalez-Koch A, Maor-Kendler Y, Batts K, Moreno-Luna L, Poterucha J, Burgart L, Wiesner R, Kremers W, Rosen C, Charlton MR.
    Hepatology; 2000 Nov 27; 32(5):1125-30. PubMed ID: 11050065
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. [Treatment of recurrent HCV infection after liver transplantation].
    Ostojić R.
    Acta Med Croatica; 2005 Nov 27; 59(5):443-6. PubMed ID: 16381241
    [Abstract] [Full Text] [Related]

  • 57. Prediction of liver allograft fibrosis after transplantation for hepatitis C virus: persistent elevation of serum transaminase levels versus necroinflammatory activity.
    Pelletier SJ, Iezzoni JC, Crabtree TD, Hahn YS, Sawyer RG, Pruett TL.
    Liver Transpl; 2000 Jan 27; 6(1):44-53. PubMed ID: 10648577
    [Abstract] [Full Text] [Related]

  • 58. Natural history of recurrent hepatitis C.
    Berenguer M.
    Liver Transpl; 2002 Oct 27; 8(10 Suppl 1):S14-8. PubMed ID: 12362293
    [Abstract] [Full Text] [Related]

  • 59. Fibrosis progression and the pros and cons of antiviral therapy for hepatitis C virus recurrence after liver transplantation: a review.
    De Martin E, Senzolo M, Gambato M, Germani G, Vitale A, Russo FR, Burra P.
    Transplant Proc; 2010 Oct 27; 42(6):2223-5. PubMed ID: 20692449
    [Abstract] [Full Text] [Related]

  • 60. Outcome of liver transplantation for patients infected by hepatitis C, including those infected by genotype 4.
    Wali MH, Heydtmann M, Harrison RF, Gunson BK, Mutimer DJ.
    Liver Transpl; 2003 Aug 27; 9(8):796-804. PubMed ID: 12884191
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.